FirstWord is a company belonging to one of the most colossal global healthcare knowledge networks. The company offers its customers a wealthy collection of reports covering various sectors of the worldwide pharmaceutical market and, thereby, providing them with unparalleled knowledge to get a leg up on other competitors in the sphere.

Prepared using the rich and reliable information sources, FirstWord’s reports grant access to the unrivalled quantitative and qualitative intelligence on the pharmaceutical industry; offer insightful market analyses; clearly describe predominant development trends; characterize the foremost factors having an effect on the market; and discuss the most burning issues having relation to the specific industry.

Research Reports By FirstWord

Found 250 publications
Malignant Melanoma: KOL Insight US$ 6,495.00 Oct, 2014
KOL Insight: Multiple Sclerosis US$ 6,495.00 Oct, 2014
Payer Insights: Hepatitis C US$ 6,495.00 Sep, 2014
Chronic Lymphocytic Leukaemia: KOL Insight US$ 4,995.00 May, 2014 116 pages
Diabetes - KOL Insight and Consensus Outlook Modules US$ 7,495.00 Feb, 2014 224 pages
1 2 3 4 5
Skip to top

News & Press-Releases by FirstWord